Patel Chavez Chandani, Morales Hernandez Maria Del Mar, Kresak Jesse, Woodmansee Whitney W
Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, USA.
Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Thyroid Res. 2022 Apr 20;15(1):7. doi: 10.1186/s13044-022-00125-5.
Amyloid goiter, defined as excess amyloid within the thyroid gland in such quantities that it produces a clinically apparent goiter, is a very rare manifestation of systemic amyloidosis with cases commonly seen in the setting of Amyloid A (AA) amyloidosis. Amyloid goiter as the primary clinical manifestation secondary to Amyloid light chain (AL) amyloidosis is very rare. We present a case of AL amyloidosis with initial manifestation as goiter with amyloid deposition in the thyroid and the parathyroid gland.
A 73 year old male presented with goiter and compressive symptoms of dysphagia and hoarseness. Laboratory workup revealed normal thyroid function, nephrotic range proteinuria, elevated serum calcium level with an elevated parathyroid hormone level (PTH) consistent with primary hyperparathyroidism. Thyroid ultrasound showed an asymmetric goiter with three dominant nodules. Cervical computed tomography revealed a goiter with substernal extension and deviation of the trachea. Fine needle aspiration was unsatisfactory. There was also evidence of osteoporosis and hypercalciuria with negative Sestamibi scan for parathyroid adenoma. The patient underwent a total thyroidectomy and one gland parathyroidectomy. Pathology revealed benign thyroid parenchyma with diffuse amyloid deposition in the thyroid and parathyroid gland that stained apple green birefringence under polarized light on Congo Red stain. Immunochemical staining detected AL amyloid deposition of the lambda type. Bone marrow biopsy revealed an excess monoclonal lambda light chain of plasma cells consistent with a diagnosis of AL amyloidosis secondary to multiple myeloma affecting the kidney, thyroid, parathyroid gland, and heart. He was treated with 4 cycles of chemotherapy with a decrease in the M spike and light chains with a plan to pursue a bone marrow transplant.
Amyloid goiter as the primary clinical manifestation secondary to AL amyloidosis with deposition in the thyroid and parathyroid gland is rare. The top differential for amyloid deposits in the thyroid includes systemic amyloidosis or medullary thyroid carcinoma. The definitive diagnosis lies in the histopathology of the thyroid tissue. To diagnose systemic amyloidosis as the etiology for a goiter, a solid understanding of the causes of systemic amyloidosis coupled with a thorough evaluation of the patient's history and laboratory data is necessary.
淀粉样变甲状腺肿定义为甲状腺内存在过量淀粉样物质,其数量足以导致临床上明显的甲状腺肿,是系统性淀粉样变的一种非常罕见的表现形式,常见于淀粉样蛋白A(AA)淀粉样变的情况下。淀粉样变甲状腺肿作为淀粉样轻链(AL)淀粉样变的主要临床表现非常罕见。我们报告一例以甲状腺肿为初始表现,伴有甲状腺和甲状旁腺淀粉样沉积的AL淀粉样变病例。
一名73岁男性因甲状腺肿及吞咽困难和声音嘶哑等压迫症状就诊。实验室检查显示甲状腺功能正常、肾病范围蛋白尿、血清钙水平升高且甲状旁腺激素水平(PTH)升高,符合原发性甲状旁腺功能亢进。甲状腺超声显示不对称性甲状腺肿,有三个主要结节。颈部计算机断层扫描显示甲状腺肿延伸至胸骨后并伴有气管移位。细针穿刺结果不理想。同时存在骨质疏松和高钙尿症的证据,甲状旁腺腺瘤的Sestamibi扫描为阴性。患者接受了全甲状腺切除术和一侧甲状旁腺切除术。病理显示甲状腺实质良性,甲状腺和甲状旁腺有弥漫性淀粉样沉积,刚果红染色在偏振光下呈苹果绿双折射。免疫化学染色检测到λ型AL淀粉样沉积。骨髓活检显示浆细胞中存在过量的单克隆λ轻链,符合继发于多发性骨髓瘤的AL淀粉样变诊断,累及肾脏、甲状腺、甲状旁腺和心脏。他接受了4个周期的化疗,M峰和轻链降低,计划进行骨髓移植。
淀粉样变甲状腺肿作为AL淀粉样变继发的主要临床表现,伴有甲状腺和甲状旁腺沉积是罕见的。甲状腺淀粉样沉积的主要鉴别诊断包括系统性淀粉样变或甲状腺髓样癌。明确诊断取决于甲状腺组织的组织病理学检查。要诊断系统性淀粉样变是甲状腺肿的病因,需要对系统性淀粉样变的病因有扎实的了解,并对患者的病史和实验室数据进行全面评估。